Published • loading... • Updated
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
The custom Korsch X3 press enhances Morpeth site’s capacity for highly potent tablets with higher containment and greater throughput, supporting clinical and commercial scale production.
- Piramal Pharma Solutions commissioned the Korsch X3 press at its Morpeth site to boost high-potency tablet production, with the unit now fully qualified and in active use.
- Morpeth recently marked 20 years of manufacturing excellence, prompting the need for advanced technology to handle growing late-phase and commercial demand for diverse tablet sizes.
- The X3 features front and dual-side glove ports with misting systems to safeguard staff from airborne contaminants, while two customized turrets support 25mm tablet manufacturing.
- Peter DeYoung, CEO, Piramal Global Pharma, said the expansion strengthens their ability to serve patients in therapeutic areas where high-potency materials are essential for complex therapies.
- This investment signals a commitment to a future where more patients benefit from Piramal's advanced capabilities across its 17 global manufacturing facilities serving over 100 countries.
Insights by Ground AI
21 Articles
21 Articles
Bennington Banner+20 Reposted by 20 other sources
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
The Korsch X3 is a state-of-the-art tablet press, custom-built to fit the site's needs.The press is equipped with full Band 5 containment, enabling the safe and contained manufacture of highly potent drug products at clinical and commercial scales.This positions Morpeth…
Coverage Details
Total News Sources21
Leaning Left1Leaning Right3Center7Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
C 64%
R 27%
Factuality
To view factuality data please Upgrade to Premium
